A wily shapeshifter, cancer hijacks a cell’s normal processes for its own ends and, too often, evades even the most promising treatments. Researchers at Whitehead Institute have helped drive steady advances in biomedicine’s understanding of cancer, contributing to innovative strategies in both diagnosis and therapy. Whitehead Institute’s longstanding leadership in cancer discovery continues, defining the specific genetic programming that makes cancer cells act differently from normal cells — and that enables cells to multiply prodigiously and spread, evading the body’s natural defenses.

Please partner with researchers such as Iain Cheeseman, David Sabatini, Richard Young, and Robert Weinberg as they make further strides toward understanding and stopping cancer.